HK1163547A1 - 含針狀活性物質的擠出物 - Google Patents

含針狀活性物質的擠出物

Info

Publication number
HK1163547A1
HK1163547A1 HK12104373.5A HK12104373A HK1163547A1 HK 1163547 A1 HK1163547 A1 HK 1163547A1 HK 12104373 A HK12104373 A HK 12104373A HK 1163547 A1 HK1163547 A1 HK 1163547A1
Authority
HK
Hong Kong
Prior art keywords
spicular
extrudate
active substances
substances
active
Prior art date
Application number
HK12104373.5A
Other languages
English (en)
Inventor
Venkata-Rangarao Kanikanti
Hans-Juergen Hamann
Peter Kleinebudde
Rieke Witzleb
Original Assignee
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41785839&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1163547(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh
Publication of HK1163547A1 publication Critical patent/HK1163547A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/606—Salicylic acid; Derivatives thereof having amino groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK12104373.5A 2008-12-05 2012-05-04 含針狀活性物質的擠出物 HK1163547A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102008060472 2008-12-05
PCT/EP2009/008341 WO2010063387A1 (de) 2008-12-05 2009-11-24 Extrudate mit nadelförmigen wirkstoffen

Publications (1)

Publication Number Publication Date
HK1163547A1 true HK1163547A1 (zh) 2012-09-14

Family

ID=41785839

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12104373.5A HK1163547A1 (zh) 2008-12-05 2012-05-04 含針狀活性物質的擠出物

Country Status (28)

Country Link
US (1) US20120034273A1 (zh)
EP (1) EP2373287B1 (zh)
JP (2) JP5860284B2 (zh)
KR (1) KR20110096145A (zh)
CN (1) CN102238940B (zh)
AR (1) AR075106A1 (zh)
AU (1) AU2009321822B2 (zh)
BR (1) BRPI0922302B8 (zh)
CA (1) CA2745456A1 (zh)
CL (1) CL2011001207A1 (zh)
CO (1) CO6440550A2 (zh)
CR (1) CR20110285A (zh)
DO (1) DOP2011000160A (zh)
EC (1) ECSP11011080A (zh)
ES (1) ES2685472T3 (zh)
HK (1) HK1163547A1 (zh)
IL (1) IL212846A0 (zh)
MX (1) MX2011005572A (zh)
NI (1) NI201100103A (zh)
NZ (1) NZ593217A (zh)
PE (1) PE20120182A1 (zh)
RU (1) RU2549450C2 (zh)
SV (1) SV2011003919A (zh)
TW (1) TWI522114B (zh)
UA (1) UA105648C2 (zh)
UY (1) UY32287A (zh)
WO (1) WO2010063387A1 (zh)
ZA (1) ZA201104145B (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU231017B1 (hu) * 2012-05-08 2019-11-28 LAVET Gyógyszeripari Kft. Praziquantel tartalmú ízfedett formulációk
EP2968569A4 (en) * 2013-03-15 2016-11-02 Argenta Mfg Ltd COUGAR FORMULATION
IN2013MU03583A (zh) * 2013-11-14 2015-07-31 Cipla Ltd
ES2947367T3 (es) 2017-07-26 2023-08-07 Tgx Soft Chew Llc Masticable blando sin almidón para aplicaciones veterinarias
EP4208157A1 (en) 2020-09-04 2023-07-12 Elanco Us Inc. Palatable formulations

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4402752B2 (ja) * 1997-05-19 2010-01-20 大日本住友製薬株式会社 免疫増強製剤
IT1298574B1 (it) * 1998-02-06 2000-01-12 Vectorpharma Int Composizioni farmaceutiche in forma di microparticelle a base polimerica ottenute mediante estrusione e sferonizzazione
DE19916383A1 (de) * 1999-03-31 2000-10-05 Schering Ag Pharmazeutische Zusammensetzung mit einem Extrusionsstoff
ATE431738T1 (de) * 2001-08-06 2009-06-15 Euro Celtique Sa Opioid-agonist-formulierungen mit freisetzbarem und sequestriertem antagonist
BR0312206A (pt) * 2002-06-27 2005-04-12 Cilag Ag Formulações de pélete esférico
TWI347201B (en) * 2003-04-21 2011-08-21 Euro Celtique Sa Pharmaceutical products,uses thereof and methods for preparing the same
US20060165790A1 (en) * 2003-06-27 2006-07-27 Malcolm Walden Multiparticulates
US20050163842A1 (en) * 2003-12-31 2005-07-28 Garth Boehm Rosiglitazone and metformin formulations
EP1566173B1 (en) * 2004-02-20 2006-08-16 Mattern, Udo Pharmaceutical composition for oral application and method for preparing thereof
EP1690528A1 (de) * 2005-02-11 2006-08-16 Abbott GmbH & Co. KG Herstellung von Dosierungsformen mit einer festen Dispersion eines mikrokristallinen Wirkstoffs
WO2006090640A1 (ja) * 2005-02-23 2006-08-31 Taiyokagaku Co., Ltd. アミノ酸含有錠剤組成物および錠剤の製造方法
DE102005062270A1 (de) * 2005-12-24 2007-06-28 Bayer Technology Services Gmbh Geschmacksmaskierung von Pulvern
US20080233156A1 (en) * 2006-10-11 2008-09-25 Alpharma, Inc. Pharmaceutical compositions
DE102007026550A1 (de) * 2007-06-08 2008-12-11 Bayer Healthcare Ag Extrudate mit verbesserter Geschmacksmaskierung
CN101590020B (zh) * 2008-05-30 2012-02-08 上海新菲尔生物制药工程技术有限公司 一种对氨基水杨酸钠结肠定位给药系统

Also Published As

Publication number Publication date
PE20120182A1 (es) 2012-02-24
WO2010063387A1 (de) 2010-06-10
UA105648C2 (uk) 2014-06-10
CA2745456A1 (en) 2010-06-10
ZA201104145B (en) 2012-09-26
CN102238940B (zh) 2014-07-30
AU2009321822B2 (en) 2015-04-16
US20120034273A1 (en) 2012-02-09
CR20110285A (es) 2011-09-27
NI201100103A (es) 2012-04-16
DOP2011000160A (es) 2011-06-30
BRPI0922302A2 (pt) 2016-01-05
BRPI0922302B1 (pt) 2020-09-15
BRPI0922302B8 (pt) 2021-05-25
AR075106A1 (es) 2011-03-09
JP2012510956A (ja) 2012-05-17
UY32287A (es) 2010-06-30
JP2015134812A (ja) 2015-07-27
RU2011127248A (ru) 2013-01-10
EP2373287B1 (de) 2018-05-30
KR20110096145A (ko) 2011-08-29
ECSP11011080A (es) 2011-06-30
AU2009321822A1 (en) 2011-06-30
TW201031422A (en) 2010-09-01
RU2549450C2 (ru) 2015-04-27
SV2011003919A (es) 2011-08-28
TWI522114B (zh) 2016-02-21
CO6440550A2 (es) 2012-05-15
MX2011005572A (es) 2011-06-16
IL212846A0 (en) 2011-07-31
NZ593217A (en) 2013-05-31
JP5860284B2 (ja) 2016-02-16
EP2373287A1 (de) 2011-10-12
CN102238940A (zh) 2011-11-09
CL2011001207A1 (es) 2011-10-28
ES2685472T3 (es) 2018-10-09

Similar Documents

Publication Publication Date Title
HRP20180718T1 (hr) Oligopeptidni spojevi i njihova upotreba
ZA201104336B (en) Pharmaceutical compounds
HK1146909A1 (zh) 除臭材料
EP2141990A4 (en) ACTIVE COMPOUNDS ON 11BETA-HSD1
GB0816372D0 (en) Pharmaceutical compounds
GB0820819D0 (en) Pharmaceutical compounds
GB0801416D0 (en) Pharmaceutical compounds
EP2116535A4 (en) GLUCKINASE ACTIVATING SUBSTANCE
GB0816371D0 (en) Pharmaceutical compounds
GB0812969D0 (en) Pharmaceutical compounds
SI2271618T1 (sl) Farmacevtske spojine
GB0816370D0 (en) Pharmaceutical compounds
EP2349990B8 (en) Aryl-phenyl-sulfonamide-phenylene compounds and their use
GB0902610D0 (en) Materials
GB0810857D0 (en) Pharmaceutical compounds
IL199771A0 (en) Active substance combination
HK1163547A1 (zh) 含針狀活性物質的擠出物
GB0715132D0 (en) Tissue-adhesive materials
TWI367210B (en) Estrogenic-active compounds and application thereof
GB0713587D0 (en) Insulaitng materials
AU2008905990A0 (en) Compounds and uses thereof
GB0812733D0 (en) Self-coalescing materials
GB0814373D0 (en) Tissue-adhesive materials
GB0820820D0 (en) Pharmaceutical compounds
GB0817006D0 (en) Pharmaceutical compounds

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20181122